Polycythemia Vera Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2022-2032), Analyzes DelveInsight | Key Companies - AOP Orphan Pharma, Italfarmaco, Kartos Therapeutics, Perseus Proteomics, Protagonist Therapeutics, Roche, Sa

As per DelveInsight, the Polycythemia Vera Market is anticipated to grow at a CAGR of 14% by 2032. The Polycythemia Vera Market is expected to grow owing to increasing awareness of the disease and the launch of the emerging therapy in the market.

DelveInsight's "Polycythemia Vera Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Polycythemia Vera Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The Polycythemia Vera market report covers emerging drugs, treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Polycythemia Vera: An Overview
Polycythemia Vera (PV) is a condition characterized by an increased number of red blood cells in the bloodstream (erythrocytosis) and affected people may also have excess white blood cells and platelets. Most cases of PV are not inherited and are acquired during a person's lifetime.

Mutation in the JAK2 kinase is responsible for PV. Most cases of PV are associated with genetic changes that are somatic, not in the egg and sperm cells, which pass on genetic information to offspring. PV is usually diagnosed in the average age of people 60-65 years. It is uncommon in people under the age of 40. PV develops more often in men than in women.

In the early stages, there are not any specific signs and symptoms. When too many RBCs and platelets build up in the blood, symptoms start to appear, which may cause a problem. The symptoms are not noticeable due to an increased cell count but can predict a higher risk of clot formation.

Polycythemia Vera Market Key Facts
• The total market size of Polycythemia Vera in the 7MM is approximately USD 1,800 million in 2022.
• Among EU4 countries, Germany accounts for the maximum market size in 2022 while Spain occupies the bottom of the ladder in 2022
• The market size of Polycythemia Vera in Japan is USD 100 million in 2022.
• The total market size of Polycythemia Vera in the United States is expected to increase with a CAGR of 14% during the study period (2019-2032).
• The total prevalent cases of Polycythemia Vera in the 7MM comprised approximately 309,000 cases in 2022 and are projected to increase during the forecasted period
• The total prevalent cases of Polycythemia Vera in the United States were around 179,000 cases in 2022
• Among the EU4 countries, Germany accounted for the largest number of Polycythemia Vera cases followed by France, whereas Spain accounted for the lowest number of cases in 2022
• In Japan, the prevalent Polycythemia Vera cases were around 13,000 in males and 7,000 in females in 2022

Polycythemia Vera Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Polycythemia Vera market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Polycythemia Vera market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Discover How Polycythemia Vera Market will Grow by 2032:
https://www.delveinsight.com/report-store/polycythemia-vera-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Polycythemia Vera Epidemiology
The epidemiology section covers detailed insights into the historical and current Polycythemia Vera patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.

The Report Covers the Polycythemia Vera Epidemiology Segmented as -
• Total Prevalent Cases of Polycythemia Vera in the 7MM [2019-2032]
• Risk-specific Cases of Polycythemia Vera in the 7MM [2019-2032]
• Gender-specific Cases of Polycythemia Vera in the 7MM [2019-2032
• Age-specific Cases of Polycythemia Vera in the 7MM [2019-2032]
• Based on Symptoms Cases of Polycythemia Vera in the 7MM [2019-2032]
• Mutation-specific Cases of Polycythemia Vera in the 7MM [2019-2032]

Get Key Insights Into the Evolving Polycythemia Vera Epidemiology Trends:
https://www.delveinsight.com/report-store/polycythemia-vera-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Polycythemia Vera Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Polycythemia Vera market or expected to be launched during the study period. The analysis covers Polycythemia Vera market uptake by drugs, patient uptake by therapies, and sales of each drug.

The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Polycythemia Vera Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities:
https://www.delveinsight.com/sample-request/polycythemia-vera-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Polycythemia Vera Therapeutics Assessment
Several major pharma and biotech companies are developing therapies for Polycythemia Vera. Currently, Protagonist Therapeutics is leading the therapeutics market with its Polycythemia Vera drug candidates in the most advanced stage of clinical development.

Leading Companies in the Polycythemia Vera Therapeutics Market Include:
• AOP Orphan Pharmaceuticals AG
• Imago BioSciences
• Ionis Pharmaceutical
• Italfarmaco
• Kartos Therapeutics, Inc.
• Perseus Proteomics
• Protagonist Therapeutics
• Roche
• Sanofi
• Silence Therapeutics
And Many Others

Polycythemia Vera Emerging and Marketed Drugs Covered in the Report Include:
• BESREMi (ropeginterferon alfa-2b): PharmaEssentia/AOP Orphan Pharmaceuticals
• Besremi: AOP Orphan Pharmaceuticals and PharmaEssentia
• Bomedemstat (IMG-7289): Imago BioSciences
• Givinostat: Italfarmaco
• Itacitinib: Incyte
• Jakafi (Ruxolitinib): Incyte Corporation/Novartis
• JAKAFI/JAKAVI (ruxolitinib): Incyte/Novartis
• KRT-232: Kartos Therapeutics
• PPMX-T003: Perseus Proteomics
• PTG-300: Protagonist Therapeutics
• Rusfertide (PTG-300): Protagonist Therapeutics
• Sapablursen (IONIS-TMPRSS6-LRx): Ionis Pharmaceutical
• SLN124: Silence Therapeutics
And Many More

Learn More About the Emerging Therapies & Key Companies in the Polycythemia Vera Therapeutics Market:
https://www.delveinsight.com/sample-request/polycythemia-vera-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Polycythemia Vera Competitive Intelligence Analysis
4. Polycythemia Vera Market Overview at a Glance
5. Polycythemia Vera Background and Overview
6. Polycythemia Vera Patient Journey
7. Polycythemia Vera Epidemiology and Patient Population
8. Polycythemia Vera Treatment Algorithm, Current Treatment, and Medical Practices
9. Polycythemia Vera Unmet Needs
10. Key Endpoints of Polycythemia Vera Treatment
11. Polycythemia Vera Marketed Products
12. Polycythemia Vera Emerging Therapies
13. Polycythemia Vera Seven Major Market Analysis
14. Attribute Analysis
15. Polycythemia Vera Market Outlook (7 major markets)
16. Polycythemia Vera Access and Reimbursement Overview
17. KOL Views on the Polycythemia Vera Market.
18. Polycythemia Vera Market Drivers
19. Polycythemia Vera Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Report's Offerings:
https://www.delveinsight.com/sample-request/polycythemia-vera-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Other Trending Healthcare Reports by DelveInsight
Bronchial Neoplasm Market
https://www.delveinsight.com/report-store/bronchial-neoplasm-market

Gastro Intestinal Bleeding Market
https://www.delveinsight.com/report-store/gastro-intestinal-bleeding-market

Orthostatic Hypotension Market
https://www.delveinsight.com/report-store/orthostatic-hypotension-market

Pars Plantis Market
https://www.delveinsight.com/report-store/pars-plantis-market

Schistosomiasis Market
https://www.delveinsight.com/report-store/schistosomiasis-market

Vulvodynia Market
https://www.delveinsight.com/report-store/vulvodynia-market

Indolent Lymphoma Market
https://www.delveinsight.com/report-store/indolent-lymphoma-market

Liver Angiosarcoma Market
https://www.delveinsight.com/report-store/liver-angiosarcoma-market

Osteochondrodysplasia Market
https://www.delveinsight.com/report-store/osteochondrodysplasia-market

Tuberous Sclerosis Complex Market
https://www.delveinsight.com/report-store/tuberous-sclerosis-complex-market

Ocular Melanoma Market
https://www.delveinsight.com/report-store/ocular-melanoma-market

Mucopolysaccharidosis I Market
https://www.delveinsight.com/report-store/mucopolysaccharidosis-i-market

Bone Resorption Market
https://www.delveinsight.com/report-store/bone-resorption-market

Hot Flashes Market
https://www.delveinsight.com/report-store/hot-flashes-market

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.